by Katie Galvin | May 17, 2022 | All Cancer Keys
17th May 2022 It is now expected that at least 80% of lower GI urgent cancer referrals should be accompanied by a Faecal Immunochemical Test (FIT) result. Potential pitfall: A negative bowel screening test should not be used to make decisions about referral in a...
by Alice Stocks | Apr 25, 2022 | All Cancer Keys
25th April 2022 Bowel cancer cases are increasing in adults aged under 50 in England, according to The British Journal of Surgery. Even though incidences of bowel cancer cases are lower in this age group than older populations, the incidence is still significantly...
by Katie Galvin | May 28, 2021 | What’s new?
28th May 2021 Missed our GatewayC Live webinar? Watch the recording here. In this webinar, GatewayC met Dr Rory Harvey, Consultant Gastroenterologist at Bedfordshire Hospitals NHS Foundation Trust. In this webinar, we explored the role and benefits of using the faecal...
by Katie Galvin | Sep 10, 2020 | All Cancer Keys
10th September 2020 Potential pitfall: Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It...
by Alice Bowden | Nov 1, 2019 | All Cancer Keys
1st November 2019 Whilst FIT can be a good indicator of bowel cancer, inflammatory bowel disease and sometimes precursors of cancer, some symptomatic patients can still have false negative results. With this in mind, how should you proceed? Potential Pitfall A normal...
Recent Comments